|Day Low/High||6.55 / 6.91|
|52 Wk Low/High||5.85 / 11.69|
Jim Cramer is bullish on Hershey, Nvidia, Accenture, Cheniere Energy. He's bearish on Emerge Energy and Seaspan.
Don't get upended by the rhetoric. The transports are confirming, banks are solid, there's a genuine uptick in commerce and earnings are strong, says Jim Cramer.
Inovio to receive up to $50 million in upfront and near term payments and equity investment
Jim Cramer names a few of his favorite things: housing, bank, material and tech stocks, oil, copper and deregulation.
Jim Cramer is bullish on Chesapeake Energy and some bank stocks. But he's bearish on Inovio Pharmaceutical.
Investors in Inovio Pharmaceuticals Inc. saw new options become available this week, for the August 2017 expiration.
Dr. David B. Weiner recognized for his innovative medical and scientific research, which has been the basis for over 100 patents
Four of five study subjects in treated group show progression free survival ranging from nine to 24 months to date in phase I/IIa clinical study
Stocks closed with gains on Monday as T-Mobile led the Nasdaq amid better-than-expected earnings, while B/E Aerospace soared following announcement of its acquisition by Rockwell Collins.
Stocks stay in the green Monday as M&A and earnings reports lead the market higher, while manufacturing orders rise.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
In trading on Friday, shares of Inovio Pharmaceuticals Inc. crossed below their 200 day moving average of $8.62, changing hands as low as $8.60 per share.
Investors in Inovio Pharmaceuticals Inc. saw new options begin trading this week, for the May 2017 expiration.
Popular Mechanics magazine calls Inovio's Zika prevention a completely new form of vaccination that may be the fastest vaccine ever to come to market
Where some see danger and upheaval, investors see opportunity. And the harrowing Zika virus is no different. Investors are jumping into stocks focused on detecting or wiping out the virus.